source
- Novo Nordisk invests $380M to expand manufacturing in Czech Republic and China, while Cellares raises $50M Series DNovo Nordisk announced a significant investment to broaden its manufacturing footprint in both China and the Czech Republic. In the Czech Republic, the company is allocating roughly $380 million t…
- Medicare $2,000 out-of-pocket cap boosts use of high-cost drugs, study showsA recent study published in JAMA Health Forum examined how the Inflation Reduction Act’s $2,000 annual out-of-pocket limit for Medicare beneficiaries affected drug consumption. The analysis found…